Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    Ikena Oncology Inc.

    NASDAQ: IKNA · Real-Time Price · USD
    1.30
    -0.04 (-2.99%)
    At close: Jun 05, 2025, 3:59 PM
    1.30
    -0.38%
    After-hours: Jun 05, 2025, 07:59 PM EDT

    Ikena Oncology Statistics

    Share Statistics

    Ikena Oncology has 48.26M shares outstanding. The number of shares has increased by -16.58% in one year.

    Shares Outstanding

    n/a
    		 48.26M

    Shares Change (YoY)

    n/a
    		 -16.58%

    Shares Change (QoQ)

    n/a
    		 0%

    Owned by Institutions (%)

    n/a
    		 65.71%

    Shares Floating

    n/a
    		 n/a

    Failed to Deliver (FTD) Shares

    n/a
    		 1

    FTD / Avg. Volume

    n/a
    		 n/a

    Short Selling Information

    The latest short interest is 115.65K, so 0.24% of the outstanding shares have been sold short.

    Short Interest

    n/a
    		 115.65K

    Short % of Shares Out

    n/a
    		 0.24%

    Short % of Float

    n/a
    		 0.27%

    Short Ratio (days to cover)

    n/a
    		 1.04

    Valuation Ratios

    The PE ratio is -1.61 and the forward PE ratio is -2.27. Ikena Oncology's PEG ratio is 0.04.

    PE Ratio

    n/a
    		 -1.61

    Forward PE

    n/a
    		 -2.27

    PS Ratio

    n/a
    		 0

    Forward PS

    n/a
    		 3.4

    PB Ratio

    n/a
    		 0.63

    P/FCF Ratio

    n/a
    		 -1.72

    PEG Ratio

    n/a
    		 0.04
    Financial Ratio History

    Enterprise Valuation

    Currently the Enterprise Value (EV) is not available for Ikena Oncology.

    EV / Sales

    n/a
    		 n/a

    EV / EBITDA

    n/a
    		 n/a

    EV / EBIT

    n/a
    		 n/a

    EV / FCF

    n/a
    		 n/a

    Financial Position

    The company has a current ratio of 11.8, with a Debt / Equity ratio of 0.06.

    Current Ratio

    n/a
    		 11.8

    Quick Ratio

    n/a
    		 11.8

    Debt / Equity

    n/a
    		 0.06

    Debt / EBITDA

    n/a
    		 -0.15

    Debt / FCF

    n/a
    		 -0.16

    Interest Coverage

    n/a
    		 0

    Financial Efficiency

    Return on Equity is n/a and Return on Invested Capital is n/a.

    Return on Equity

    n/a
    		 n/a

    Return on Assets

    n/a
    		 n/a

    Return on Invested Capital

    n/a
    		 n/a

    Revenue Per Employee

    n/a
    		 n/a

    Profits Per Employee

    n/a
    		 $-4,923,400

    Employee Count

    n/a
    		 10

    Asset Turnover

    n/a
    		 0

    Inventory Turnover

    n/a
    		 n/a

    Taxes

    Income Tax

    n/a
    		 152K

    Effective Tax Rate

    n/a
    		 -0.31%

    Stock Price Statistics

    The stock price has increased by -26.14% in the last 52 weeks. The beta is 0.45, so Ikena Oncology's price volatility has been higher than the market average.

    Beta

    n/a
    		 0.45

    52-Week Price Change

    n/a
    		 -26.14%

    50-Day Moving Average

    n/a
    		 1.18

    200-Day Moving Average

    n/a
    		 1.5

    Relative Strength Index (RSI)

    n/a
    		 61.32

    Average Volume (20 Days)

    n/a
    		 99,473

    Income Statement

    Revenue

    n/a
    		 n/a

    Gross Profit

    n/a
    		 n/a

    Operating Income

    n/a
    		 -58.97M

    Net Income

    n/a
    		 -49.23M

    EBITDA

    n/a
    		 -48.59M

    EBIT

    n/a
    		 -49.08M

    Earnings Per Share (EPS)

    n/a
    		 -1.02
    Full Income Statement

    Balance Sheet

    The company has 39.39M in cash and 7.52M in debt, giving a net cash position of 31.87M.

    Cash & Cash Equivalents

    n/a
    		 39.39M

    Total Debt

    n/a
    		 7.52M

    Net Cash

    n/a
    		 31.87M

    Retained Earnings

    n/a
    		 -331.62M

    Total Assets

    n/a
    		 130.84M

    Working Capital

    n/a
    		 108.21M
    Full Balance Sheet

    Cash Flow

    In the last 12 months, operating cash flow was -46M and capital expenditures 0, giving a free cash flow of -46M.

    Operating Cash Flow

    n/a
    		 -46M

    Capital Expenditures

    n/a
    		 n/a

    Free Cash Flow

    n/a
    		 -46M

    FCF Per Share

    n/a
    		 -0.95
    Full Cash Flow Statement

    Margins

    Gross Margin

    n/a
    		 n/a

    Operating Margin

    n/a
    		 n/a

    Pretax Margin

    n/a
    		 n/a

    Profit Margin

    n/a
    		 n/a

    EBITDA Margin

    n/a
    		 n/a

    EBIT Margin

    n/a
    		 n/a

    FCF Margin

    n/a
    		 n/a

    Dividends & Yields

    IKNA does not appear to pay any dividends at this time.

    Dividend Per Share

    n/a
    		 n/a

    Dividend Yield

    n/a
    		 n/a

    Dividend Growth (YoY)

    n/a
    		 n/a

    Payout Ratio

    n/a
    		 n/a

    Earnings Yield

    n/a
    		 n/a

    FCF Yield

    n/a
    		 n/a
    Dividend Details

    Analyst Forecast

    The average price target for IKNA is $4, which is 207.7% higher than the current price. The consensus rating is "Buy".

    Price Target

    n/a
    		 $4

    Price Target Difference

    n/a
    		 207.7%

    Analyst Consensus

    n/a
    		 Buy

    Analyst Count

    n/a
    		 1
    Stock Forecasts

    Fair Value

    There are several formulas that can be used to estimate the intrinsic value of a stock.

    Lynch Fair Value

    n/a
    		 n/a

    Lynch Upside

    n/a
    		 n/a

    Graham Number

    n/a
    		 n/a

    Graham Upside

    n/a
    		 n/a

    Scores

    Altman Z-Score

    n/a
    		 -1.26

    Piotroski F-Score

    n/a
    		 1

    Add to Watchlist